| Extracellular magnesium and calcium reduce myotonia in ClC-1 inhibited rat muscle M Skov, A Riisager, JA Fraser, OB Nielsen, TH Pedersen Neuromuscular Disorders 23 (6), 489-502, 2013 | 29 | 2013 |
| Extracellular magnesium and calcium reduce myotonia in isolated ClC‐1 chloride channel‐inhibited human muscle M Skov, FV De Paoli, J Lausten, OB Nielsen, TH Pedersen Muscle & Nerve 51 (1), 65-71, 2015 | 24 | 2015 |
| The anti‐convulsants lacosamide, lamotrigine, and rufinamide reduce myotonia in isolated human and rat skeletal muscle M Skov, FV de Paoli, OB Nielsen, TH Pedersen Muscle & Nerve 56 (1), 136-142, 2017 | 16 | 2017 |
| Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy A Mankodi, C Grunseich, M Skov, L Cook, G Aue, E Purev, D Bakar, ... Neuromuscular Disorders 25 (11), 908-912, 2015 | 11 | 2015 |
| The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis M Skov, TQ Ruijs, TS Grønnebæk, M Skals, A Riisager, JB Winther, ... Science translational medicine 16 (739), eadk9109, 2024 | 3 | 2024 |
| ClC-1 Inhibition as a Novel Mechanism for Accelerating Recovery of Skeletal Muscle Function After Neuromuscular Block in an Experimental Rat Model T Pedersen, M Skals, M Broch-Lips, M Skov, A Riisager, J Ceelen, ... | | 2024 |
| Role of recovery of acetylcholine release in compromised neuromuscular junction function JB Winther, JJ Morgen, M Skov, MG Broch-Lips, OB Nielsen, K Overgaard, ... Neuromuscular Disorders 36, 48-59, 2024 | | 2024 |
| Compounds for the treatment of neuromuscular disorders LJS Knutsen, N Kelly, MB Skov, A Riisager, N Saraswat US Patent App. 17/620,294, 2022 | | 2022 |
| Alterations in fast‐twitch muscle membrane conductance regulation do not explain decreased muscle function of SOD1G93A rats PA Leermakers, M Skov, A Riisager, OB Nielsen, TH Pedersen Muscle & Nerve 64 (6), 755-764, 2021 | | 2021 |
| Improving NMJ Transmission Fidelity: An Additional Target in SMA?(1999) GM Owendoff, MB Skov, N Losievski, KM Corlett, D Chugh, VL McGovern, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
| Rufinamide for use in the treatment of myotonia TH Pedersen, MB Skov US Patent App. 16/061,293, 2018 | | 2018 |
| Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington’s disease M Skov, RT Dirksen Journal of General Physiology 149 (1), 49-53, 2017 | | 2017 |
| Anti-myotonic Effects of Extracellular Divalent Cations and Clinically Used Anti-epileptica: PhD Dissertation MB Skov Aarhus University, Department of Biomedicine, 2017 | | 2017 |
